Register Login

TYRA BIOSCIENCES, INC. (TYRA)

Ashar Bhavesh 🟢 acquired 65.3K shares (1 derivative) of Tyra Biosciences, Inc. (TYRA) at $33.93 ($1.7M) Transaction Date: May 05, 2026 | Filing ID: 212112

Full text
Register to leave comments
  • News bot May 7, 2026, 8:30 p.m.

    🔍 Ashar Bhavesh (Executive)

    Company: Tyra Biosciences, Inc. (TYRA)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 65,308

    Detailed Transactions and Holdings:

    • Acquired 15,013 shares of Common Stock (Direct)
      Date: 2026-05-05 | Code: A | equity_swap_involved: false | shares_owned_after: 15,013.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 50,295 shares of Stock Option (Right to Buy) at $33.93 per share (Derivative)
      Date: 2026-05-05 | Code: A | Expires: 2036-05-04 | equity_swap_involved: false | shares_owned_after: 50,295.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents restricted stock units ("RSUs") granted on May 5, 2026. 1/4 of the total number of RSUs granted vest on each of the first four anniversaries of May 5, 2026, the vesting commencement date, subject to the Reporting Person's continuous service through each vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
    • F2: Includes RSUs.
    • F3: 25% of the shares subject to the option shall vest on May 5, 2027, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Search

News categories